Yearly Publication Trends - sars cov 2 virus

Year	Publication Count
2024	3393
2023	9831
2022	8835
2021	8045
2020	4338
2019	13
2018	NA
2017	2
2016	3
2015	NA
2014	3

Relevant Publications

Characterization of proinflammatory cytokines profile during acute SARS-CoV-2 infection in people with human immunodeficiency virus.

Issue Release: 2024

14-3-3 Family of Proteins: Biological Implications, Molecular Interactions, and Potential Intervention in Cancer, Virus and Neurodegeneration Disorders.

Issue Release: 2024

Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy.

Issue Release: 2024

A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments.

Issue Release: 2024

Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in Rajasthan.

Issue Release: 2024

Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles.

Issue Release: 2024

Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19.

Issue Release: 2024

SARS-CoV-2-related peptides induce endothelial-to-mesenchymal transition in endothelial capillary cells derived from different body districts: focus on membrane (M) protein.

Issue Release: 2024

Single-molecule detection of SARS-CoV-2 N protein on multilayered plasmonic nanotraps with surface-enhanced Raman spectroscopy.

Issue Release: 2024

UnCoVar: a reproducible and scalable workflow for transparent and robust virus variant calling and lineage assignment using SARS-CoV-2 as an example.

Issue Release: 2024

Machine learning-based QSAR and LB-PaCS-MD guided design of SARS-CoV-2 main protease inhibitors.

Issue Release: 2024

COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.

Issue Release: 2024

Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1.

Issue Release: 2024

Impact of in vitro SARS-CoV-2 infection on breast cancer cells.

Issue Release: 2024

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.

Issue Release: 2024

An Emerging Network for COVID-19 CT-Scan Classification using an ensemble deep transfer learning model.

Issue Release: 2024

PDZ2-conjugated-PLGA nanoparticles are tiny heroes in the battle against SARS-CoV-2.

Issue Release: 2024

Influenza A, Influenza B, human respiratory syncytial virus and SARSCoV-2 molecular diagnostics and epidemiology in the post COVID-19 era.

Issue Release: 2024

New Vaccines for Chronic Respiratory Patients.

Issue Release: 2024

Hand-held all-in-one (HAO) self-test kit for rapid and on-site detection of SARS-CoV-2 with colorimetric LAMP.

Issue Release: 2024

Is the COVID-19 Vaccine Safe for Heart Failure Patients?

How is the HPV Vaccine Administered?

What are Placebo-Controlled Trials?

What are the goals of EPI?

Who Should Receive Vaccine Training?

Why Are They Important?

What Challenges Do Vaccine Researchers Face?

What is Measles?

Are There Any Contraindications for the Hepatitis B Vaccine?

Who Should Get the Varicella Vaccine?

Partnered Content Networks

Relevant Topics